Ownership history in XTX Topco Ltd Β· 11 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in TELADOC HEALTH INC (TDOC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π XTX Topco Ltd underperformed the S&P 500 by β108.9% annually on this TDOC position. Timing score: 30% (3/10 decisions correct). Average cost basis: $18.88. Maximum drawdown during holding period: β95.7%.
β Significantly underperformed the S&P 500 by 108.9% ann.
10 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
3 of 10 add/trim decisions correct
Best entry: $7.96 (2025 Q1) Β· Worst: $181.75 (2021 Q1)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
6 adds Β· 5 trims. Bought during 4 of 9 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.01% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size